TG-101209
A potent, selective, orally bioavailable JAK2 inhibitor with IC50 of 6 nM; also inhibits FLT3 (IC50=25 nM) and RET (IC50=17 nM) kinases, weakly inhibits JAK3 (IC50=168 nM) ; inhibits growth of Ba/F3 cells expressing JAK2V617F or MPLW515L mutations with IC50 of 200 nM, induces cell cycle arrest and apoptosis, and inhibits phosphorylation of JAK2V617F, STAT5 and STAT3; attenuates myelofibrosis in murine model of JAK2V617F-induced polycythemia vera; also potently inhibits BRD4 with Kd of 123 nM.Bone Cancer Preclinical.
Product Specifications
CAS Number
936091-14-4
Product Name Alternative
SAR-317461
Purity
>98% (HPLC)
Solubility
10 mM in DMSO
Smiles
O=S (C1=CC=CC (NC2=NC (NC3=CC=C (N4CCN (C) CC4) C=C3) =NC=C2C) =C1) (NC (C) (C) C) =O
Molecular Formula
C26H35N7O2S
Molecular Weight
509.6668
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
Benzenesulfonamide, N- (1,1-dimethylethyl) -3-[[5-methyl-2-[[4- (4-methyl-1-piperazinyl) phenyl]amino]-4-pyrimidinyl]amino]-
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Human Leydig cell tumor 10 kDa protein homolog, C19orf53 ELISA Kit
Human Leydig cell tumor 10 kDa protein homolog, C19orf53 ELISA Kit
Human Leydig cell tumor 10 kDa protein homolog, C19orf53 ELISA Kit
Human Leydig cell tumor 10 kDa protein homolog, C19orf53 ELISA Kit